Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nutritional High International Inc. Ordinary Shares SPLID

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
High Fusion Inc is engaged in the manufacturing, processing, and distribution of infused edible products. The company's operating and geographical segments include Palo Verde; Pasa Verde; Oregon; Colorado; Nevada and Washington. It generates maximum revenue from the Palo Verde segment.


OTCPK:SPLID - Post by User

Nutritional High International Inc. Ordinary Shares > Hmmm...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(274)
•••
Comment by LiquidOctopusV2on Nov 01, 2019 9:48am
62 Views
Post# 30296617

RE:Hmmm...

RE:Hmmm...Long regualtory approvals aren't unique to Nutritional High's case.  Just ask Cresco Labs. 

mrmonopoly wrote: CHV and BUZZ strike major supply deal, both of whom EAT has partnerships/agreements/stake with... Hmmm wonder who orchestrated this deal...

Personally I'm over the GT deal. It doesn't make nearly as much sense to me anymore for the price they're paying, plus it's taken way too long to execute. If they hadn't sunk so much money and resources into it at this point I'd say drop the deal and go all in on Pharmadrug which better aligns with their distribution business model. BUZZ is very cheap right now AND EAT already has a sizeable stake from previous investments.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities